Summary
- Main use
- Nutritional improvement through intravenous nutrition (amino acids and calories) and supplementation with fluids and electrolytes
- Who receives it
- Adults
- Adult administration
- Administer by central venous infusion. Determine the infusion rate based on the total dose, the characteristics of the final admixture to be infused, the daily dose, and the infusion time. In general, gradually increase the dose over the first 30 minutes of infusion until the appropriate dose is reached. There is no set limit on the duration of administration; however, appropriate minerals and vitamins should be provided during long-term administration. Do not exceed a maximum infusion rate of 1.7mL/kg/hour. (Equivalent to amino acids 0.1 g/kg/hour, glucose 0.24 g/kg/hour, and fat 0.07g/kg/hour) Determine the dose according to the patient's condition, energy expenditure, and metabolic requirements. - Determine the dose according to the patient's nutritional status and degree of catabolism, but do not exceed 40kcal/kg per day. Exceptions may be made in special cases, such as patients with burns. - Maximum daily dose: 35mL per kg of the patient's body weight (equivalent to amino acids 2.0g, glucose 5.04g, and fat 1.4g per kg of body weight)
Ingredients
- Glucose Monohydrate158.4g / 1000mL
- Monobasic Sodium Phosphate Dihydrate2496mg / 1000mL
- Zinc Acetate Hydrate7.024mg / 1000mL
- Soybean Oil20g / 1000mL
- Triglycerides Medium-Chain20g / 1000mL
- Isoleucine3.288g / 1000mL
- L-Leucine4.384g / 1000mL
- Lysine Hydrochloride3.984g / 1000mL
- Methionine2.736g / 1000mL
- Phenylalanine4.92g / 1000mL
- Threonine2.544g / 1000mL
- Tryptophan0.8g / 1000mL
- Valine3.608g / 1000mL
- Arginine3.784g / 1000mL
- L-Histidine Hydrochloride Monohydrate2.368g / 1000mL
- Alanine6.792g / 1000mL
- Aspartic Acid2.104g / 1000mL
- Glutamic Acid4.912g / 1000mL
- Glycine2.312g / 1000mL
- Proline4.76g / 1000mL
- Serine4.2g / 1000mL
- Sodium Hydroxide1.171g / 1000mL
- Sodium Chloride0.378g / 1000mL
- Sodium Acetate Hydrate0.25g / 1000mL
- Potassium Acetate3.689g / 1000mL
- Magnesium Acetate Tetrahydrate0.91g / 1000mL
- Calcium Chloride Hydrate0.623g / 1000mL
- Importer
- B.Braun Korea Co., Ltd
Efficacy & effects
Nutritional improvement through intravenous nutrition (amino acids and calories) and supplementation with fluids and electrolytes
View approved original textHide original text
This medication is used to supply fluids, electrolytes, amino acids, and calories to patients who cannot take food orally or where nutrition intake through the gastrointestinal tract is insufficient, thereby replenishing essential nutrition.
How it is given
Adult administration
Administer by central venous infusion. Determine the infusion rate based on the total dose, the characteristics of the final admixture to be infused, the daily dose, and the infusion time. In general, gradually increase the dose over the first 30 minutes of infusion until the appropriate dose is reached. There is no set limit on the duration of administration; however, appropriate minerals and vitamins should be provided during long-term administration. Do not exceed a maximum infusion rate of 1.7mL/kg/hour. (Equivalent to amino acids 0.1 g/kg/hour, glucose 0.24 g/kg/hour, and fat 0.07g/kg/hour) Determine the dose according to the patient's condition, energy expenditure, and metabolic requirements. - Determine the dose according to the patient's nutritional status and degree of catabolism, but do not exceed 40kcal/kg per day. Exceptions may be made in special cases, such as patients with burns. - Maximum daily dose: 35mL per kg of the patient's body weight (equivalent to amino acids 2.0g, glucose 5.04g, and fat 1.4g per kg of body weight)
Precautions
This medication must be used strictly according to a doctor's instructions, and the administration should be stopped immediately if allergic reactions such as fever, chills, rash, or breathing difficulties occur. When used with intravenous calcium preparations, mixing should be avoided, and particular caution is needed when used with ceftriaxone due to potential precipitation. It is safer not to administer to premature or low-birth-weight infants, as their lipid metabolism capacity is low and poses a risk. It should not be administered to patients with specific conditions such as premature infants, newborns, those allergic to eggs or soybean oil, severe renal failure, or liver disease. Administer carefully to patients with renal failure, pancreatitis, liver dysfunction, heart failure, and diabetes while frequently monitoring blood lipid levels and other test values. Excessive or rapid administration may cause side effects, so caution is necessary, and if symptoms such as fever, breathing difficulties, or vomiting occur, administration should stop immediately. During prolonged administration, regular tests of liver function and blood tests should be performed to detect adverse reactions early. Before administration, ensure that the patient's hydration, electrolyte, and acid-base balance is normal, and if lipid metabolism abnormalities are suspected, check blood lipid levels before administration. This medication may raise blood glucose levels, so blood glucose should be monitored periodically, and insulin dosages adjusted accordingly if needed. If anaphylaxis or hypersensitivity reactions are suspected, administration should be stopped immediately, and appropriate measures taken. Maintain aseptic conditions during administration to prevent infection, use immediately after opening and do not store any leftover medication. Be aware of potential drug interactions when used in combination with other medications, and consult a professional beforehand. Particularly, care should be taken not to administer it concurrently with blood. The safety for pregnant or breastfeeding women has not been established, so the benefits and risks should be carefully considered before administration. When testing after administration, the drug's lipid component may affect the test results, so blood sampling should ideally be done 5-6 hours after administration. Signs of excess dosage may include acidosis, hypervolemia, hyperglycemia, dehydration, pulmonary edema, so inform medical personnel immediately and seek appropriate treatment. Store the medication in undamaged packaging, protect it from light, and store it at a temperature between 15-25 degrees Celsius, avoiding freezing.
Side effects
fever, chills, rash, shortness of breath, elevated body temperature, sweating, headache, vomiting, increased liver function test values, liver enlargement, jaundice, thrombophlebitis, hyperlipidemia syndrome, fever, fat deposition, splenomegaly, anemia, leukopenia, thrombocytopenia, blood clotting abnormalities, coma, flushing, chills, loss of appetite, nausea, respiratory distress, pain in the thoracic and lumbar spine area, increased blood pressure, decreased blood pressure, hypersensitivity symptoms, skin erythema, cyanosis, local fat accumulation, pathological liver function abnormalities, abnormal blood symptoms, abdominal pain, fatigue, phlebitis, vascular irritation symptoms, thrombophlebitis, vomiting, nausea, abdominal pain, fatigue, bleeding
Not everyone experiences these, and they can vary from person to person.
Storage
This medication should be stored in a sealed container to avoid exposure to air or light, important to keep away from direct sunlight, and at a cool temperature between 15 and 25 degrees Celsius.
Appearance and packaging
Appearance
Acolorless, transparent liquid emulsion contained in a bag made of polyamide and polypropylene materials, divided into three compartments - two on the top and one at the bottom.
Package unit
Bag - 1250 milliliters / Bag
Questions about this medicine
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.